SEEDS

Seeds continue to be utilised in his practice with outstanding results in the appropriately chosen patients. Generally, these patients are people with a low-risk prostate cancer, with minimal urinary symptoms, in middle-age, particularly those wanting a less invasive form of therapy and a very rapid recovery.

Recently he did a review of his cases where there was at least a two-year follow-up and up to 14 year follow up.. In looking at over 500 of his cases the results were as follows:

  • Cancer-specific survival 100%.
  • Local recurrence 3%.
  • Urinary incontinence (mild) 1%.
  • Erectile dysfunction 30%.

Ideal patients - Gleason 3 + 3 or Gleason 3 + 4 cancer with 50% of the biopsies cores tended to fare less well. Furthermore, patients with PSAs of >15 or patients with Gleason >3 + 4, also did not do as well with seed therapy alone (see Table 1).

SEEDS results

Seed therapy therefore remains an excellent option for middle-aged patients with low-risk or intermediate-risk low-volume disease in patients wishing a less invasive treatment option and a rapid recovery.

 

Key aspects

From diagnosis and treatment to rehabilitation and research, I believe my highly experienced team and I bring a multifaceted approach to understanding and helping our patients. A summary of these key aspects of that approach is available here in PDF format. If you are suffering from prostate cancer or have reason to believe you might be, you are welcome to contact us or, intially, complete our comprehensive second opinion form.